Comparing Kiwi Actinidin Reports Requires the Same Substrate and Reporting Basis

Actinidin is a protease, so its measured activity concerns cleavage of a test substrate under specified conditions. An activity result is different from a protein concentration. It is also different from the behavior of kiwi in a dairy, plant-protein or other food formulation. Laboratory results can help design a useful ingredient comparison, while the intended food system requires its own trial.

Consider a hypothetical formulation team asking GreenLand to compare two reports: one per millilitre of extract and another per gram of fruit, with their substrates still unconfirmed. We would clarify the analytical definitions before interpreting the difference. The next commercial step would be to confirm the offered kiwi form and process and test that sample in the intended formulation. This scenario illustrates a purchasing decision; it does not describe a historical GreenLand customer or a measured supplier batch.

An activity unit is defined by its test

An enzyme activity unit expresses a rate under stated analytical conditions. For proteases, the observable response may concern soluble products released from a protein substrate, cleavage of a selected peptide, a color response or another validated endpoint. The laboratory converts that response into activity using its stated definition. A number described as U is therefore incomplete until the report explains what one unit means and how it was determined.

The substrate is central to that definition. Casein, gelatin and a defined synthetic peptide present different structures and cleavage opportunities. An enzyme can act differently on those materials even when the same sample is tested. A casein-based activity result and a peptide-based result should remain separately identified until a justified relationship has been established. Changing the substrate is more than changing a reagent name at the bottom of the report.

Reaction pH, temperature, substrate concentration and incubation time also belong to the result. A method may use conditions chosen to make a stable, reproducible assay signal. Those conditions need not match a refrigerated drink or a heated preparation. The unit describes the assay environment. The purchasing team should request that environment alongside the concentration basis, particularly when two laboratories are using different methods or different versions of a method.

A protease encounters a substrate with susceptible bonds; cleavage depends on the substrate and assay conditions.

The actinidin purification paper by Dhiman and colleagues describes a casein assay, a reaction interval and temperature, and a unit definition based on released tyrosine. That example demonstrates why an activity number needs its procedural context. The same paper reports extract activity and protein-based specific activity. These are useful distinctions for reading reports, but its extraction buffer and purified-enzyme results are not a recommended commercial recipe or evidence about an offered frozen kiwi lot.

The response calculation deserves a short explanation from the laboratory. Ask whether a blank or control was used, which part of the signal was attributed to proteolysis, and whether sample color or turbidity required correction. Fruit extracts can contain more than the target enzyme. A valid procedure should account for matrix effects relevant to its detector. The buyer does not need to redesign the assay, but should understand whether the reported activity is suitable for the actual sample.

Method version and laboratory scope make the comparison repeatable. Record the named procedure, any modification and the sample matrix covered by validation. A published method reference alone may leave extraction changes or unit calculations unstated. When a laboratory adapts the procedure for frozen pieces, it should explain what changed and how suitability was checked. This is particularly useful when an ingredient approval will be repeated across future orders.

A protease activity assay may establish the behavior of the tested extract without uniquely identifying every active protein. If the purchasing claim names actinidin specifically, ask how enzyme identity or attribution is supported. Zymography, targeted protein analysis or other suitable evidence can complement an activity measurement. These approaches answer different questions; the report should not quietly replace identity evidence with a nonspecific protein-cleavage response.

The practical acceptance request is therefore method-specific. State the substrate and unit definition, the relevant reaction conditions and the reporting basis. Ask the laboratory to identify any deviations. A result outside a numerical range can then be interpreted against a stable analytical requirement. Without those fields, a supplier and buyer may disagree about activity while each is accurately describing a different test.

Per extract volume and per fruit mass answer different questions

U/mL tells the reader how much measured activity is associated with one millilitre of the tested extract under the assay. It can be useful for dosing an extract in a laboratory experiment. It does not state how much original fruit produced that millilitre. A dilute extract and a concentrated extract can have different U/mL values even if they were prepared from fruit with comparable recoverable activity. Extraction and dilution need to be read before judging the ingredient.

U/g fruit requires a relationship between the measured extract and the original fruit mass. A transparent calculation normally uses measured activity per extract volume, the relevant total extract volume and the mass of fruit represented, with any necessary dilution correction. The laboratory should state which volumes are included and whether the final result has already been corrected. Applying the factor again can produce an erroneous result that looks formally precise.

For a purely illustrative calculation, an extract measured at 10 U/mL, with 50 mL recovered from 100 g fruit, represents 5 recovered U/g fruit before any additional correction. If another 50 mL of buffer is then added and no activity is lost, the concentration falls to 5 U/mL while total recovered units stay the same. The fruit-basis value also stays at 5 U/g. These invented numbers explain the denominator; they are not GreenLand data or a recommended extraction ratio.

Dilution changes units per millilitre while total recovered units and fruit basis can remain constant.

Recovery adds a separate question. A fruit-basis result calculated from an extract reports the activity recovered by that extraction. It does not automatically represent every active enzyme molecule in the original fruit. Some activity may remain in solids, change during handling or be affected by the extraction environment. Ask whether the laboratory reports recovered activity or uses a validated recovery correction. An extraction yield and a recovery percentage need explicit definitions because the words can describe different quantities.

The 2022 study of Green and SunGold kiwi reports activity per millilitre of extract and approximate activity per gram of fresh fruit. It also gives extraction-yield information. Its table provides a concrete example of why the volume-to-mass relationship belongs in the interpretation. The study's particular numerical values should not become commercial limits for frozen kiwi. Cultivar, sample handling and experimental procedure constrain what those values describe.

"Per gram" also needs a material description. It might mean peeled flesh, whole fruit, fresh mass, dry matter, recovered protein or an extract solid. Those denominators answer different questions. A purchasing team comparing frozen peeled pieces should identify which of them corresponds to the delivered ingredient. If peel or seeds were included in one extraction and excluded in another, a denominator correction alone may not make the sample compositions equivalent.

Wet and dry bases can be converted only with suitable moisture data and a clear calculation. Such a conversion changes the denominator while preserving the interpretation of the assay itself. It cannot compensate for different substrates or different extraction recovery. Keep the original reported value in the technical file and record the converted value, input measurements and calculation beside it. This preserves an audit trail when development reviews the result later.

The most efficient comparison may be to ask one laboratory to prepare both representative samples by the same procedure. That reduces the number of unresolved factors, although it does not remove variation among fruit pieces or lots. When matched testing is unavailable, record which differences remain and avoid ranking the samples from unmatched numbers. A clear statement that the evidence is not yet comparable is more useful than an apparently decisive ratio built on missing information.

Protein quantity is not active actinidin quantity

Protein concentration measures a material quantity or analytical response associated with proteins. Protease activity measures a reaction under specified conditions. A kiwi extract contains proteins other than actinidin, and a protein measurement does not establish which proteins are present or how actively they cleave the assay substrate. The two measurements can support one another in research, but they need separate names and units in a purchasing request.

U/mg protein is commonly described as specific activity. Its numerator is activity under the assay; its denominator is measured protein. During purification, removal of proteins that do not contribute to the measured activity may raise U/mg protein. That increase does not necessarily mean more total activity was recovered from the starting fruit. A small, purified fraction can have high specific activity while representing only part of the original extracted units.

An illustrative comparison makes the distinction visible. Suppose an extract contains 100 total assay units and 10 mg measured protein, giving 10 U/mg. A recovered fraction containing 60 units and 2 mg protein gives 30 U/mg. Specific activity is higher, while total recovered activity is lower. These hypothetical values describe arithmetic rather than a kiwi lot. A buyer should decide whether purity, extract dosing or activity per delivered ingredient is the relevant objective before comparing the fractions.

Purification can raise U/mg protein while reducing recovered total activity; the values are illustrative.

Protein-based denominators also depend on the protein assay. A colorimetric method and a nitrogen-based estimate can respond to the sample differently. The 2022 kiwi paper distinguishes nitrogen-derived crude protein from measured enzyme activity. Neither a crude-protein percentage nor an arbitrary conversion factor establishes active actinidin concentration. Record the protein method if U/mg protein is part of the agreed specification, and keep it consistent when the ratio is used for comparison.

Enzyme identity requires suitable evidence of its own. The kiwi zymography study examined activity on gelatin-containing gels and identified selected active spots by mass spectrometry. That approach distinguishes a visible proteolytic response from the protein attributed to it. A gel band by itself is not a commercial actinidin activity certificate. Conversely, detecting a protein sequence does not quantify its rate of action in the buyer's formulation. Each result needs its correct scope.

Activity can change without an equal change in total protein quantity. Handling, temperature, acidity and other conditions can affect the enzyme's functional state. A protein may remain detectable after its activity has changed. This is one reason why a total-protein number is an unsuitable replacement for an activity assay when the purchasing decision concerns proteolysis. It is also a reason to record sample preparation and storage before the assay.

For frozen kiwi, ask whether the tested material is a crude fruit extract, a purified enzyme preparation or the delivered ingredient prepared by the agreed laboratory procedure. A purified research enzyme has a different matrix from frozen flesh. Its behavior can explain a mechanism but does not qualify the offered SKU. If a supplier presents purified-enzyme information as supporting literature, retain it as background and request separate evidence appropriate to the actual ingredient.

A clear technical file can contain protein quantity, enzyme identity, assay activity and extraction recovery without forcing them into a single quality score. Purchasing can then see which evidence is available and which evidence is still required. We would confirm the offered kiwi form and available laboratory scope before making an activity commitment. A product's green color, visible seeds or frozen condition does not resolve any of these analytical fields.

A different food protein is a separate performance test

An assay substrate is chosen for measurement. A food formulation contains a more complex protein environment, together with water, salts, fat, carbohydrates, acids and processing effects. The enzyme's access to susceptible bonds can differ from its access in a laboratory substrate solution. A matched assay may provide a reliable analytical comparison while still leaving the application question open. Both tests can be useful when their objectives are explicit.

Kaur and colleagues studied several food proteins in a simulated gastric model and observed that kiwi extract affected some proteins differently from others. The result supports a limit on transfer between substrates within that model. It does not establish a refrigerated yogurt holding time, a treatment recipe for a protein beverage or a benefit to people consuming the ingredient. The model's conditions and food proteins must remain attached to the finding.

The later Green and SunGold investigation also used controlled in vitro digestion conditions. Its activity measurements helped describe the extracts used in the experiments. A formulation buyer can learn from the relationship among enzyme activity, protein source and experimental environment, while maintaining a separate food-development question. The commercial trial should use the actual offered kiwi, rather than substitute a paper's extract or infer performance from its activity table.

Protein structures present different cleavage opportunities. This schematic does not predict a formulation hold.

For a protein formulation, begin by defining what acceptable performance means. It might concern consistency, visible separation, texture, flavor or another product-specific attribute over an intended hold. Those attributes should be observed under the processing and storage route the development team intends to use. An enzyme assay does not supply an acceptance criterion for them automatically. A trial without a clear objective can produce observations that purchasing cannot translate into a specification.

Keep the kiwi inclusion and formulation basis transparent. If samples have different water contributions or physical forms, decide whether the comparison uses equal delivered mass, equal fruit solids or another justified basis. Record the choice and maintain the rest of the formulation consistently. Different cut sizes may change the distribution of fruit and contact with the protein phase, even when a homogenized laboratory extract gives a similar activity result.

Time, temperature and mixing should also be recorded. Kiwi may be added frozen, partially thawed or fully prepared before incorporation. These choices can affect the conditions encountered by the ingredient in the food system. A development trial should follow the intended route closely enough to answer the commercial question. If several routes are being screened, treat them as separate experimental conditions rather than pool their observations into one ingredient rating.

The visible product form identifies the material to qualify; composition and activity require separate evidence.

Use a suitable control. A current approved kiwi input can provide a commercial reference, while a formulation without kiwi may help clarify a formulation effect when that question is relevant. The control and candidate need comparable preparation and assessment conditions. A blinded presentation is useful for sensory comparison when visible product differences can be managed appropriately. Instrumental texture or separation measurements should remain distinct from preference judgments.

If an assay and application trial appear to disagree, inspect the differences in matrix and preparation before assuming a laboratory error. The activity assay may be operating under a favorable substrate environment, while the food system presents different conditions. Alternatively, the sampling or method basis may be unmatched. Preserve both observations and investigate the specific uncertainty. A clean separation of endpoints makes that discussion more productive than trying to force the application into the laboratory unit.

The resulting approval should identify the food system and its operating range. A sample accepted in one formulation may still require qualification in another protein system or under another process. The buyer can use the analytical result to support consistency monitoring, provided its relationship to that particular application has been established appropriately. A universal guarantee across dairy, plant-protein and meat systems cannot be inferred from a single activity value.

Build a comparable kiwi activity request

Write the analytical request as a complete measurement description. Include the kiwi species or cultivar information available for the offer, physical form, process history, sample condition, extraction procedure, substrate, unit definition and reaction conditions. Identify the desired denominator and ask the laboratory to retain the original reported basis. These details allow the analyst to advise on method suitability and allow purchasing to interpret the result without reconstructing missing calculations.

Extraction yield needs a defined field in the report. Ask for the fruit mass represented, final relevant extract volume, dilution and any recovery correction. If the result is converted to U/g fruit, request the calculation and confirm whether it refers to wet or dry mass and to which fruit fraction. If U/mg protein is also reported, request the protein method. Each denominator should remain visible rather than be shortened to a general "activity content" label.

Specify the comparison objective before asking for a limit. A team selecting an extract for laboratory dosing may prioritize U/mL. A team comparing recoverable activity from an ingredient may prefer U/g of a defined fruit mass. A purification project may need U/mg protein and total recovery. A food manufacturer approving frozen kiwi still needs evidence on the delivered product and the intended formulation. The correct denominator follows the decision being made.

Assay conditions affect observed reaction rates; curves are conceptual and have no fitted kiwi parameters.

For a significant sourcing choice, ask about variation at the appropriate stages. Repeated detector readings of the same extract describe only part of the analytical uncertainty. Separately prepared test portions help characterize extraction and preparation variation. Representative sampling helps address differences among fruit pieces. The number of preparations and acceptance rules should be agreed with the laboratory and the purchasing team in proportion to the importance of the decision.

The hypothetical formulation team can send GreenLand its reports, unit definitions and intended food-protein system. We would ask for the substrate, assay conditions, extraction yield and original basis before interpreting the difference. We would then confirm the offered kiwi product and review available testing. Unmatched activity values would not become an assured performance claim. Development would retain a separate trial on the actual candidate ingredient under the intended process.

Commercial specifications remain relevant alongside analytical details. The kiwi form, size, maturity description, packing, quantity and destination need confirmation for the order. These facts help identify the material being tested and prevent a sample from being approved for a different presentation. They do not substitute for a validated activity method. A chemical or enzymatic comparison also does not replace the required food-safety and destination-market documentation for supply.

The visible product form identifies the material to qualify; composition and activity require separate evidence.

Retain the method version and the sample identity with every approval. If the laboratory changes its substrate, extraction or unit calculation, reconsider whether the established numerical range remains suitable. If a supplier changes cultivar or processing, assess whether additional qualification is required. Historical activity numbers can provide context, but their comparability depends on the same definitions that made the original test useful. A consistent archive makes that review faster.

The final purchasing record should show analytical comparability and formulation approval separately. The first explains what the laboratory measured and how the values were brought onto a common basis. The second identifies the actual food, inclusion, preparation and accepted performance. We help purchasing teams confirm the requested evidence and available supply information before committing to an order. That approach gives the next analyst or developer enough detail to repeat the comparison and understand its practical limits.

Continue reading about frozen kiwi

Design a yogurt trial around fruit form, preparation and intended hold.

Compare juice yield, seed handling and pulp when selecting the kiwi presentation.

Review freezing preparation and texture changes before choosing the ingredient form.